Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Phibro Animal Health (PAHC) Receivables - Net (2016 - 2025)

Phibro Animal Health has reported Receivables - Net over the past 13 years, most recently at $215.9 million for Q4 2025.

  • Quarterly results put Receivables - Net at $215.9 million for Q4 2025, up 12.56% from a year ago — trailing twelve months through Dec 2025 was $215.9 million (up 12.56% YoY), and the annual figure for FY2025 was $228.0 million, up 33.39%.
  • Receivables - Net for Q4 2025 was $215.9 million at Phibro Animal Health, down from $217.9 million in the prior quarter.
  • Over the last five years, Receivables - Net for PAHC hit a ceiling of $228.0 million in Q2 2025 and a floor of $135.6 million in Q1 2021.
  • Median Receivables - Net over the past 5 years was $158.7 million (2022), compared with a mean of $167.5 million.
  • Biggest five-year swings in Receivables - Net: decreased 10.55% in 2021 and later soared 35.53% in 2025.
  • Phibro Animal Health's Receivables - Net stood at $142.5 million in 2021, then increased by 6.55% to $151.8 million in 2022, then dropped by 0.79% to $150.6 million in 2023, then rose by 27.33% to $191.8 million in 2024, then increased by 12.56% to $215.9 million in 2025.
  • The last three reported values for Receivables - Net were $215.9 million (Q4 2025), $217.9 million (Q3 2025), and $228.0 million (Q2 2025) per Business Quant data.